Programs in Biological Technology

Remuda Ranch Programs for Eating and Anxiety Disorders Reports Need for Increasing Awareness of Eating Disorders in Males

PHOENIX, July 2 /PRNewswire/ -- As many as five to ten million males in the U.S. struggle quietly with an eating disorder because they're ashamed to admit they have the illness, reports Remuda Ranch Programs for Eating and Anxiety Disorders . Healthcare professionals, family members and close...

OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting

BOTHELL, WA and VANCOUVER, May 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that final survival data from a randomized Phase 2 trial evaluating OGX-011 in combination with docetaxel versus docetaxel alone as first-line chemotherapy in patients with ...

Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver

CAMBRIDGE, Mass., April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported data from its three hepatitis C development programs being pr...

URAC Director of Pharmacy Programs to Speak at Academy of Managed Care Pharmacy Annual Meeting

To Provide Overview of Pharmacy Benefit Management Accreditation Standards WASHINGTON, April 16 /PRNewswire-USNewswire/ -- URAC , the leading health care accreditation and education organization, announced today that Director of Pharmacy Programs Janice Anderson, RPh, has been selected to ...

What Will Be the Impact of Programs of Study?

LOUISVILLE, Ky., April 15 /PRNewswire-USNewswire/ -- The National Research Center for Career and Technical Education (NRCCTE), funded by the Office of Vocational and Adult Education at the U.S. Department of Education, recently published a report that focuses on the question: What Will Be the Impa...

Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)

INSMED WILL CONTINUE TO MANAGE ALS EAP IN ITALY AND ALL IPLEX(TM) INITIATIVES IN THE U.S. IDIS WILL HAVE RESPONSIBILITY FOR REST OF WORLD RICHMOND, Va., March 30 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a biopharmaceutical company, today announced the ...

Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)

CAMBRIDGE, Mass., March 18 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that four abstracts from the company's hepatitis C antiviral...

Three Firms, Two Training Programs Garner Greater Baltimore Committee's 2009 Bioscience Awards

BALTIMORE, March 12 /PRNewswire-USNewswire/ -- Maryland biotech CEOs and companies were honored today by the Greater Baltimore Committee as winners of the region's fourth bioscience award competition. Winners of the 2009 Bioscience Awards are: Best New Product or ...

Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform

COLUMBIA, S.C., March 3 /PRNewswire-FirstCall/ -- Collexis Holdings Inc. (OTC Bulletin Board: CLXS), a leading developer of semantic search and knowledge discovery software, announced today the launch of the world's first CTSA Experts Platform drawing on the research profiles of 38 institution...

McCulley/Cuppan Announced Today The Launch Of A New Series Of Web-Based Training Programs For Professionals In The Biopharmaceutical And Life Science Industries

McCulley/Cuppan announced today the launch of a new series of web-based training programs for professionals in the biopharmaceutical and life science industries. The web delivered "short" courses are one hour in duration and designed specifically for the busy professional looking to ref...

Waters Corporation Gives Boost to Clinical Research Programs at University of Sherbrooke Hospital

QUEBEC, Oct. 29 /PRNewswire/ -- The Fondation du Centre hospitalier universitaire de Sherbrooke (CHUS) is proud to announce that Waters Corporation has donated a Waters(R) Synapt(TM) MS System, the latest generation of mass spectrometers. This gift -- worth a total C$1.1 million -- is the resu...

Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder

SAN CARLOS, Calif., Oct. 21 /PRNewswire-FirstCall/ -- (11:00 PM PT, Oct. 20) -- Nektar Therapeutics (Nasdaq: NKTR ) today announced that Novartis AG has agreed to acquire from Nektar specific pulmonary delivery assets, technology, and intellectual property for $115 million in cash. "This ag...

MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position

KANSAS CITY, Mo., Oct. 13 /PRNewswire-USNewswire/ -- Midwest Research Institute (MRI) today announced the formation of a new Center for Integrated Algal Research and the appointment to a newly created position, the Director of Energy Programs. "Reducing America's dependence on foreign oil is...

Pharmaxis Research Programs Highlighted at European Respiratory Society Congress

SYDNEY, Australia, Oct. 3 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS, NASDAQ: PXSL) has announced that researchers will present 12 abstracts from its respiratory disease program at the 2008 European Respiratory Society Congress (ERS) being held in Berlin from t...

Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting

SAN DIEGO, Sept. 16 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA ) announced today that the Company will present preclinical data on RDEA594, its lead product candidate for the treatment of gout, as well as preclinical data on RDEA119,its lead mitogen-activated ERK kinase (...

Touch Bionics unveils innovative partner and reimbursement programs at AOPA

New programs designed to support the growing number of US clinics CHICAGO, IL, Sept. 10 /PRNewswire/ - Touch Bionics, developer of the world's first commercially available bionic hand, today revealed details of two new support programs at the 2008 National Assembly of the American Orthotic a...

Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV

Report: Hundreds of Studies Show that Programs to Curb Unsafe Sex and Drug Use are Highly Effective, but Often Overlooked in Global AIDS Response MEXICO CITY, Aug. 5 /PRNewswire/ -- In a new report released today, an international panel of AIDS experts calls on global leaders to aggressively...

Amylin Pharmaceuticals to Present Promising Data From Diabetes and Obesity Programs at ADA 2008

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced that the company will present new data for its FDA-approved diabetes drugs, BYETTA(R) (exenatide) injection and SYMLIN(R) (pramlintide acetate) injection, and its pipeline diabetes and obe...

Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections

BOSTON, April 16 /PRNewswire/ -- Paratek Pharmaceuticals, Inc. announced today that it has closed the second and final tranche of a $40 million private financing. As previously announced, Aisling Capital led the financing, with additional participation by new investors, the D.E. Shaw group and...

ARIUS presents new findings for anti-cancer antibody programs at AACR

-ARIUS report new data and program updates on cancer stem cell targeting antibodies- TORONTO, April 15 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announc...

Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storage

LOS ANGELES, April 11 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company ( http://www.cordblood-america.com ) focused on bringing the life saving potential of stem cells to families nationwide and international...

Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting

BELLEVUE, WA, April 10 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY) announced today that data from preclinical studies of PX-478, pharmacodynamic studies of PX-12 and preclinical studies of PX-866 will be presented at the Annual Meeting of the American Association for C...

Peregrine Pharmaceuticals Remains on Track to Advance its Three Lead Clinical Programs in 2008

-Five New Clinical Trial Sites Recently Initiated To Support Ongoing Trials- -Clinical Data Expected in 2008 from Seven Ongoing or Planned Clinical Trials, Including Four Phase II Trials in Major Disease Indications- -Revenues Plus Cash On-Hand Expected to ...

Rigel to Present Research Programs at Scientific Conferences

SOUTH SAN FRANCISCO, Calif., Oct. 16 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that its scientists will be presenting three poster presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Franc...

Pediatric Asthma Programs Featuring PARI Pharma's eFlow Acquired by AstraZeneca

MONTEREY, Calif., Sept. 24 /PRNewswire/ -- Today, the rights to Verus Pharmaceuticals' pediatric asthma development programs that utilize PARI's eFlow electronic nebulizer for aerosol delivery were acquired by AstraZeneca. Following Gilead Sciences' acquisition of Corus Pharma in August 2006, ...

Healthy Advice Networks Announces Improved Patient Outcomes in Physicians' Offices with Healthy Advice Programs

Higher Percentage of Patients Have Preventative Testing CINCINNATI, June 23 /PRNewswire/ -- Healthy Advice Networks , the nation's leading provider of physician office-based patient-education programs, reports that in practices with Healthy Advice educational programs, 16.9 percent more...

ImQuest Presentations at CROI Report Significant Advances in Therapeutic and Microbicide Product Development Programs

FREDERICK, Md., Feb. 20 /PRNewswire/ -- ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the 16th Conference on Retroviruses and Opportunistic Infections held last week in Montreal. Presentations focus...

Alere Offers Single-Source Solution for Health Plans Seeking to In-Source Health Management Programs

Many health plans are moving to in-source Disease Management and Health Services programs to control costs and improve member outcomes Alere's robust Integrated Health Management Solution(IHMS) platform fully integrates a wide range of programs on a sin...

P2R Associates Presented with Eight MarCom Awards for Client Strategic Communication Programs

LIVONIA, Mich., Jan. 22 /PRNewswire/ -- P2R Associates today announced it received eight prestigious MarCom Awards sponsored by the Association of Marketing and Communication Professionals. The awards were presented recognizing outstanding creative achievement by marketing and communication p...

MAP Pharmaceuticals Provides Update on Progress of Two Phase 3 Clinical Programs

MOUNTAIN VIEW, Calif., Jan. 12 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced continued progress with its two Phase 3 clinical programs, Unit Dose Budesonide (UDB) for children with asthma and MAP0004 for the acute treatment of migraine. For UDB, all pat...

Vical Reports Third Quarter 2008 Financial Results and Continued Progress in Product Development Programs

SAN DIEGO, Nov. 5 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL) today reported financial results for the quarter ended September 30, 2008. Revenues for the third quarter of 2008 were $0.8 million, compared with revenues of $0.4 million for the third quarter of 2007. The net loss ...

Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs

PRSA San Diego honored Gable PR with one Silver Bernays Mark of Merit award, for superior execution in a global communications campaign for the Biotechnology Industry Organization's (BIO) 2008 BIO International Convention. The agency also received two Bronze Bernays Mark of Merit awards for the ...

Oncothyreon announces prioritization plan for development programs

SEATTLE, Sept. 2 /PRNewswire-FirstCall/ - Oncothyreon Inc. (NASDAQ: ONTY) (TSX: ONY) (the "Company") today announced a prioritization plan to focus the Company's resources on the clinical development of PX-478 and PX-866 and on process development and manufacturing of Stimuvax(R). Oncothyreon ...

IDIS Opens New American Office in Response to Industry's Growing Need for Pre-Launch Named Patient Programs

LONDON, Aug. 26 /PRNewswire/ -- IDIS, the world leader in the development and implementation of pre-launch Named Patient Programs (NPPs), announces the opening of a new regional office in Iselin, New Jersey, USA. This office places IDIS in a stronger position to support US based pharmaceutical...

Consistency, Flexibility Key in Improving Rewards & Recognition Programs

CHAPEL HILL, N.C., Aug. 11 /PRNewswire/ -- "Rewards and recognition are driven from an internal program around creating superior value for our customers, both external and internal," said one participant in a member-driven research study conducted by Best Practices, LLC's GLOBAL BENCHMARKING C...

AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs

WILMINGTON, Del., July 23 /PRNewswire-FirstCall/ -- More than a third of the people who contacted AstraZeneca (NYSE: AZN ) to inquire about the company's prescription savings programs learned of the programs from their doctors or pharmacists, according to a year-long survey of more than 12,00...

Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs

BERKELEY HEIGHTS, N.J., June 5 /PRNewswire-FirstCall/ --Genta Incorporated (OTC Bulletin Board: GNTA) announced today that the Company has entered into definitive agreements with institutional and accredited investors to place Senior Secured Convertible Notes due 2010 totaling in aggregate up ...

Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs

PRINCETON, N.J., May 30 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that it is implementing the next step in its ongoing effort to focus its resources on the company's clinical and la...

Kosan Restructures Workforce to Focus Resources on Lead Clinical Programs

HAYWARD, Calif., March 18 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN ) today announced that the company will reduce its workforce by approximately 37% in order to focus resources on supporting advancement of its lead clinical programs, tanespimycin in multiple myel...

Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs

-Expands PDE10 Collaboration with Amgen- -Company to Host Conference Call at 9:00 A.M. EDT- MONTVALE, N.J., March 12 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced that it has realigned its operations, reallocated its resources...